Clinical Trial: Bevacizumab for the Treatment of Corneal Neovascularization

Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional




Official Title: Topical/Subconjunctival Injection of Bevacizumab(Avastin) for the Treatment of Corneal Neovascularization

Brief Summary: The purpose of the current study is to assess the efficacy and safety of the inhibitory effect of bevacizumab (Avastin) with different routes including topical and subconjunctival application on corneal neovascularization in the human eyes.